Justin Renz - Dec 26, 2023 Form 4 Insider Report for ARDELYX, INC. (ARDX)

Role
Chief Financial Officer
Signature
/s/ Elizabeth Grammer, Attorney-in-Fact for Justin Renz
Stock symbol
ARDX
Transactions as of
Dec 26, 2023
Transactions value $
-$1,355,873
Form type
4
Date filed
12/28/2023, 05:44 PM
Previous filing
Nov 22, 2023
Next filing
Jan 18, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARDX Common Stock Options Exercise $74.3K +75K +22.56% $0.99* 407K Dec 26, 2023 Direct F1
transaction ARDX Common Stock Sale -$1.43M -225K -55.22% $6.36 182K Dec 26, 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARDX Stock Option (Right to Buy) Options Exercise $0 -75K -38.27% $0.00 121K Dec 26, 2023 Common Stock 75K $0.99 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 12, 2023.
F2 This transaction was executed in multiple trades in prices ranging from $6.28 to $6.45, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3 The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 6, 2022, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.